SASCHA ROTH FIGURED THAT WHEN have cancer in your colon and lymph nodes and your oncologist calls you after business hours, two days before you're scheduled to begin a brutal five-week course of radiation therapy, it's probably not good news-especially when the first thing she says is, "Are you sitting down?"
Roth was the first patient that enrolled into a clinical trial to test a new immunotherapy drug, designed to unleash the body's natural immune response on the tumor cells, on patients with early stage cancers. The results were miraculous: One hundred percent of the patients went into total remission-perhaps the first time that's ever happened in any cancer clinical trial, according to Luis Diaz, head of the division of solid tumor oncology in Memorial Sloan Kettering's Department of Medicine and a designer of the trial. The trial suggested the new therapies, if delivered early enough, might not only obviate the need for traditional therapies notorious for their brutal side effects, like chemo, radiation and surgery. They could potentially cure the disease altogether.
Roth's doctor was jubilant: "We've reviewed all your scans, biopsies-everything," she says the doctor told her. "There is zero sign of cancer. We can't radiate you knowing there's no cancer in your body."
The trial, published last year in The New England Journal of Medicine, electrified the field of cancer research and held out the promise of a powerful new approach that might help relieve many people from the suffering and anxiety caused by a scourge that kills 610,000 people each year in the U.S.
ãã®èšäºã¯ Newsweek Europe ã® December 01 - 08, 2023 (Double Issue) çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ Newsweek Europe ã® December 01 - 08, 2023 (Double Issue) çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
Wendi McLendon-Covey
AFTER 10 YEARS OF PLAYING BEVERLY GOLDBERG ON THE GOLDBERGS, Wendi McLendon-Covey was not eager for a break. \"I need to go do a job where I can just throw everything at it and then come home totally exhausted.\"
'I'm the Highest Earner in Esports'
Johan \"NOtail\" Sundstein has won over $7 million but says, \"I don't really crave that status...I play for my own reasons\"
AMERICA'S BEST Weight Loss CLINICS & CENTERS 2025
WHETHER IT'S FOR MEAL PLANS, PROFESSIONAL guidance or access to medications like GLP-1s, weight loss clinics can offer personalized assistance for those hoping to make sustainable lifestyle changes.
AMERICA'S MOST ANTICIPATED NEW VEHICALS - 2025
WHETHER IT'S A NEWLY IMAGined sport utility vehicle or the re-emergence of a highly regarded halo car, the vehicles coming to market in 2025 prove that Americans' attitudes about personal transportation are diverse and are being served from all angles.
'THIS IS WHAT DEMOCRACY LOOKS LIKE'
What Donald Trump's historic U.S. presidential election victory means to America - and the world
Trump Won, Mainstream Media Lost
A broken business model exacerbated by a collapse in influence has the Fourth Estate entering another Donald Trump term in trouble
Falling for Romance
A new book, Nora Ephron at the Movies, celebrates the writer/director best known for her iconic rom-coms and strong female characters
Cracking the Norse Code
Walrus DNA has shown that Vikings were likely the first to have encountered Indigenous North Americans
Monumental Shift
The discovery of 165-million-year-old crystals Easter Island has upended the longheld notion of how the Earth's \"conveyor belt\" moves
'OUR FOREIGN POLICY AND DOMESTIC REFORMS ARE TWO SIDES OF THE SAME COIN'
It is a well-known fact across the globe that the North Korean regime is irrational and unpredictable, but we have been consistent in strengthening our defense posture against the threat from North Korea since the Korean War, and I believe that their conventional capability is much inferior to that of the Korean military.